Correlation Between Salesforce and BioNTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salesforce and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and BioNTech SE, you can compare the effects of market volatilities on Salesforce and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and BioNTech.

Diversification Opportunities for Salesforce and BioNTech

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Salesforce and BioNTech is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Salesforce i.e., Salesforce and BioNTech go up and down completely randomly.

Pair Corralation between Salesforce and BioNTech

Considering the 90-day investment horizon Salesforce is expected to generate 1.43 times less return on investment than BioNTech. But when comparing it to its historical volatility, Salesforce is 1.29 times less risky than BioNTech. It trades about 0.04 of its potential returns per unit of risk. BioNTech SE is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  9,375  in BioNTech SE on August 25, 2024 and sell it today you would earn a total of  1,985  from holding BioNTech SE or generate 21.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy98.96%
ValuesDaily Returns

Salesforce  vs.  BioNTech SE

 Performance 
       Timeline  
Salesforce 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.
BioNTech SE 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady essential indicators, BioNTech disclosed solid returns over the last few months and may actually be approaching a breakup point.

Salesforce and BioNTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salesforce and BioNTech

The main advantage of trading using opposite Salesforce and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.
The idea behind Salesforce and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios